ARCHIVES

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

DCE Board Recompetition Concepts

July 17, 1987

Advisors Approve Lung Screening Trial Testing Spiral CT Vs. X-Ray, For $200M.

November 23, 2001

RFAs For New Improve Accrual Of Minorities, Women

February 2, 1996

Senate confirms McClellan to head CMS. NCI “redeploys” $54.5 million cut from divisions to fund strategic initiatives.

March 26, 2004

Surgical Oncologists Honor HHS Secretary

March 22, 2002

Roche Markets CMV Test in Europe

April 29, 2011